Saturable active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier leads to nonlinear distribution of elacridar to the central nervous system.
about
Cyclosporine-inhibitable cerebral drug transport does not influence clinical methadone pharmacodynamics.Bioluminescent imaging of ABCG2 efflux activity at the blood-placenta barrierThe Drug Excipient Cyclodextrin Interacts With d-Luciferin and Interferes With Bioluminescence Imaging(R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP.Effects of selected OATP and/or ABC transporter inhibitors on the brain and whole-body distribution of glyburide.Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2Using positron emission tomography to study transporter-mediated drug-drug interactions in tissues.Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies.Renal Drug Transporters and Drug Interactions.Pantoprazole Induces Apoptosis of Leukemic Cells by Inhibiting Expression of P-Glycoprotein/Multidrug Resistance-Associated Protein-1 Through PI3K/AKT/mTOR Signaling.The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions.
P2860
Q36036200-371182F8-6AA1-447D-BC1C-BCEB8F896EF7Q36555565-77171645-7A3F-4B5F-B09A-214E0A630FADQ37170669-844FD77D-1495-4A0F-8E9C-BD21729D6F1DQ37177013-AC0566C8-6BD8-4AD3-A1E2-9B932892D9F6Q37207803-CCFC1C87-AFB6-44E0-963A-E388E131DBD0Q37409373-91FC34E1-56C5-4D9C-8E62-B4DBD2CB7D89Q38200490-D45E8321-C221-4BFD-A897-31C47E4160A7Q38856951-47C85B2F-3F55-429B-9E7C-D10A059E3A73Q39140289-7CBEDFD9-21F4-4828-8640-D1183F2892A1Q47597731-BCA300C1-698B-4150-8193-F7BEC0F42CF8Q48107672-7C517681-886A-4B33-8910-7AA0E6049C1B
P2860
Saturable active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier leads to nonlinear distribution of elacridar to the central nervous system.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Saturable active efflux by p-g ...... to the central nervous system.
@ast
Saturable active efflux by p-g ...... to the central nervous system.
@en
type
label
Saturable active efflux by p-g ...... to the central nervous system.
@ast
Saturable active efflux by p-g ...... to the central nervous system.
@en
prefLabel
Saturable active efflux by p-g ...... to the central nervous system.
@ast
Saturable active efflux by p-g ...... to the central nervous system.
@en
P2093
P2860
P356
P1476
Saturable active efflux by p-g ...... to the central nervous system.
@en
P2093
Rajendar K Mittapalli
Ramola Sane
Sagar Agarwal
William F Elmquist
P2860
P304
P356
10.1124/JPET.112.199786
P407
P577
2013-02-08T00:00:00Z